Tags : Finland

Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test

Tuba Khan April 23, 2020

Shots: Shots: The company receives EUA for its Novodiag COVID-19 molecular diagnostic test used to detect SARS-CoV-2 virus rapidly and is now available in Finland and under process for obtaining EUA in Sweden, UK and France The Novodiag COVID-19 assay qualitatively detects SARS-CoV-2 (orf1ab and N genes) directly from nasopharyngeal swabs and will operate using […]Read More

Biosimilars Biotech

Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab, biosimilar)

Vartika Singh October 25, 2018

Shots: Amgevita is indicated to treat chronic inflammatory diseases such as moderate-to-severe RA, IBD and psoriasis Amgen Biosimilar Amgevita, is a novel adalimumab’s biosimilar to be marketed in Finland. On 23 Mar, 2017 Amgevita received EU approval for inflammatory diseases in adults In 2013, Orion marketed first infliximab’s biosimilar in Finland post its marketing approval. […]Read More

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Janssen Signs a Research Agreement with TenNor to Develop Treatments for Nontuberculous Mycobacteria Diseases

Boehringer Ingelheim Collaborates with Cure Genetics to Develop Next-Generation Liver-Targeted Gene Therapy

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Henlius’ HLX15 (biosimilar, daratumumab) Receives IND Approval for Multiple Myeloma in China

Celltrion Report Results of CT-P59 in P-II/III Study for COVID-19

The US Government to Purchase Additional Doses of Regeneron’s Casirivimab and Imdevimab to Combat COVID-19

Tessa’s CD30 CAR-T Therapy Receives EMA’s PRIME Designation for Relapsed or Refractory Classical Hodgkin Lymphoma

Genmab’s Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA’s Approval for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Nanobiotix Presents Results of NBTXR3 (PEP503) in P-Ib/II Study for Rectal Cancer at ASCO-GI 2021

Tags : Finland

Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test

Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab, biosimilar)

Latest Posts

ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App

Philips to Acquire Capsule Technologies for ~$635M

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Tags : Finland

Latest Posts

Categories

Related Topics